Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.
about
Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?Evaluating the costs and benefits of pneumococcal vaccination in adults.The full benefits of adult pneumococcal vaccination: A systematic review.
P2860
Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cost-effectiveness of polysacc ...... e aged 65 and above in Poland.
@en
type
label
Cost-effectiveness of polysacc ...... e aged 65 and above in Poland.
@en
prefLabel
Cost-effectiveness of polysacc ...... e aged 65 and above in Poland.
@en
P2093
P2860
P356
P1476
Cost-effectiveness of polysacc ...... e aged 65 and above in Poland.
@en
P2093
Aleksandra Kobryń
Laure Durand
Pawel Grzesiowski
Pierre-Emmanuel Puig
Raquel Aguiar-Ibáñez
P2860
P304
P356
10.4161/HV.21571
P577
2012-10-01T00:00:00Z